Safety of endoscopist-administered deep sedation with propofol in patients ASA III.
Por:
Medina-Prado L, Martínez J, Bozhychko M, Mangas-Sanjuan C, Compañy Català L, Ruiz Gómez F, Aparicio Tormo JR and Casellas Valde JA
Publicada:
1 ene 2022
Ahead of Print:
13 dic 2021
Resumen:
INTRODUCTION: Deep sedation controlled by the endoscopist is safe in patients with low anesthetic risk (ASA I-II). However, scarce evidence is available in patients with intermediate risk (ASA III). OBJETIVE: To evaluate the safety of deep sedation with propofol controlled by the usual endoscopy staff (endoscopist, nurse, assistant) in outpatients classified as ASA III and the risk factors for the occurrence of complications during deep sedation in these patients. DESIGN: This observational and single-centre cross-sectional study includes consecutive patients undergoing non-complex procedures in which deep sedation is administered by the endoscopy staff. Patients were divided into group I (ASA=III) and group II (ASA
Filiaciones:
:
Endoscopia Digestiva, Hospital General Universitario de Alicante , España
:
Endoscopia Digestiva, Hospital General Universitario de Alicante , España
:
Endoscopia Digestiva, Hospital General Universitario de Alicante , España
:
Endoscopia Digestiva, Hospital General Universitario de Alicante , España
:
Endoscopia Digestiva, Hospital General Universitario de Alicante , España
:
Endoscopia Digestiva, Hospital General Universitario de Alicante , España
:
Endoscopia Digestiva, Hospital General Universitario de Alicante , España
:
Endoscopia Digestiva, Hospital General Universitario de Alicante, España
gold
|